Results 1 to 10 of about 147,528 (279)
T-cell non-Hodgkin’s lymphomas develop following transformation of tissue resident T-cells. We performed a meta-analysis of whole exome sequencing data from 403 patients with eight subtypes of T-cell non-Hodgkin’s lymphoma to identify mutational ...
Christine L. Jones+7 more
doaj +2 more sources
Cutaneous T-cell Lymphoma. [PDF]
Cutaneous T-cell lymphomas comprise a heterogeneous group of diseases characterized by monoclonal proliferations of T lymphocytes primarily involving skin, modified skin appendages, and some mucosal sites. This article addresses the basic clinical, histologic, and immunohistochemical characteristics of this group of diseases, with additional attention ...
M. Pulitzer
semanticscholar +6 more sources
Care and treatment for primary cutaneous lymphoma-associated ulcers: Two case reports [PDF]
Primary cutaneous lymphoma is a heterogeneous group of cutaneous lymphocytic primary tumors belonging to the extranodal category of non-Hodgkin lymphoma.
Min Wei+4 more
doaj +2 more sources
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
Primary cutaneous lymphomas comprise a group of lymphatic malignancies that occur primarily in the skin. They represent the second most common form of extranodal non-Hodgkin’s lymphoma and are characterized by heterogeneous clinical, histological ...
Kazuyasu Fujii
doaj +2 more sources
Differential diagnosis of erythroderma is challenging in dermatology, especially in differentiating erythrodermic cutaneous T-cell lymphoma from erythrodermic inflammatory dermatoses.
Jingru Sun+7 more
doaj +1 more source
Cutaneous T cell lymphoma (CTCL) represents a heterogeneous group of non-Hodgkin lymphoma distinguished by the presence of clonal malignant T cells. The heterogeneity of malignant T cells and the complex tumor microenvironment remain poorly characterized.
Xiangjun Liu+27 more
semanticscholar +1 more source
Key Points Final ALCANZA data confirm more durable responses and longer PFS with brentuximab vedotin vs control in CD30+ cutaneous T-cell lymphoma. Brentuximab vedotin extended the time to next treatment vs physician's choice, suggesting that durable ...
S. Horwitz+25 more
semanticscholar +1 more source
Immunomodulation in Cutaneous T Cell Lymphoma [PDF]
Martina Ferranti+3 more
doaj +5 more sources
Cutaneous T cell lymphoma is a generally indolent disease derived from skin-homing mature T cells. However, in advanced stages, cutaneous T cell lymphoma may manifest aggressive clinical behaviour and lead to a poor prognosis.
Bufang Xu+11 more
doaj +1 more source
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
Mycosis fungoides and Sézary syndrome are rare and largely incurable types of cutaneous T-cell lymphoma with limited therapeutic options. In 1984 Bunn et al.
Janika Gosmann+4 more
doaj +1 more source